Skip to content
New Cybersecurity Vulnerabilities Discovered in Clinical Trial Systems

New Cybersecurity Vulnerabilities Discovered in Clinical Trial Systems

First seen 14 Nov 2026, 19:46 UTC •
API

Article Content

Browse articles
ThreatCluster AI
ThreatCluster •November 14, 2026 at 19:47 UTC
  • •Two vulnerabilities in clinical trial systems reported on November 14, 2026.
  • •Potential exposure of sensitive patient data is a primary concern.
  • •No active exploitation confirmed, but vigilance is advised.

On November 14, 2026, two separate vulnerabilities were reported in clinical trial systems related to K. Lalitha and S. Jagan. These vulnerabilities potentially expose sensitive patient data and could lead to unauthorized access. The vulnerabilities are not yet confirmed to be, but they have raised concerns within the healthcare sector. The specific CVEs related to these vulnerabilities have not been disclosed in the articles. Organizations using affected systems are advised to monitor for updates and apply patches as they become available. The current status of these vulnerabilities is under investigation, with no known exploits reported at this time.

Start a free Starter trial for enhanced analysis

Ask AI about this cluster

Updated 4h ago How this analysis works

Timeline

2026-11-14
Vulnerabilities reported
Two vulnerabilities related to K. Lalitha and S. Jagan were reported, raising concerns in the healthcare sector.
NCBI
2026-11-14
Healthcare sector alerted
Organizations using clinical trial systems are advised to monitor for updates and apply patches as they become available.
NCBI

More articles in this cluster (2)

Extracted Entities

1 / 2

Common questions

Are these vulnerabilities actively exploited?
No active exploitation has been confirmed as of now.
What systems are affected?
The vulnerabilities affect clinical trial systems related to K. Lalitha and S. Jagan.
What should organizations do?
Organizations should monitor for updates and apply patches as they become available.